Adalimumab vs Baricitinib

## Adalimumab vs Baricitinib: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Baricitinib**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Baricitinib**: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Baricitinib — 12 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Baricitinib — C16H17N7O2S.

**Molecular Weight**: Adalimumab — N/A; Baricitinib — 371.4170 g/mol.

**Type**: Adalimumab — Antibody; Baricitinib — Small molecule.